New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
08:43 EDTFLMLFlamel Technologies secures $15M in financing
Deerfield Management announced that it had closed a transaction with Flamel Technologies and two of Flamel's subsidiaries to provide $15M. The objective of the financing is to enable Flamel to continue development programs and regulatory filings related to its internal pipeline of products. Deerfield provided the $15M in return for notes bearing 12.5% interest that amortize over a period from 18 months to 4 years. Deerfield also received a royalty of 1.75% of net sales of certain products being developed by Flamel's U.S. subsidiary, Eclat Pharmaceuticals, and transaction fee. The structure was responsive to Flamel's cash flow requirements and interest in avoiding equity dilution.
News For FLML From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 5, 2015
10:52 EDTFLMLFlamel confirms exclusive licensing agreement with Perrigo
Subscribe for More Information
09:56 EDTFLMLPerrigo and Flamel enter into exclusive licensing agreement for LiquiTime
Perrigo (PRGO) and Flamel (FLML) announced that they have entered into an exclusive licensing agreement for LiquiTime(R) extended release suspension. The technology will be utilized in the development of a portfolio of extended release suspension products intended for the U.S. OTC marketplace.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use